Waters Corporation
Waters Corporation Amends Credit Agreement
Summary
On May 22, 2025, Waters Corporation amended its credit agreement to remove its existing term loan facility of up to $200 million and retained its senior unsecured revolving credit facility of up to $1.8 billion, maturing on May 22, 2030, with potential for a one-year extension. The Company may also request additional commitments up to $750 million, subject to lender discretion. Interest rates and facility fees vary based on leverage ratios and credit ratings. The Company can use the revolving facility for general corporate purposes and has the right to prepay without penalties. The Amendment contains covenants and representations, warranties, and events of default.
Profitelligence Alerts
Get alerts for WAT
Be first to know when Waters Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Official SEC Documents
Advertisement